Autoimmune hepatitis: Mycophenolate mofetil vs. azathioprine as first-line therapy

被引：0
|
作者：
Simseki, Cem [1 ]
Wahlin, Staffan [2 ,3 ]
Efe, Cumali [1 ,4 ]
机构：
[1] Hacettepe Univ, Dept Gastroenterol, Ankara, Turkiye
[2] Karolinska Inst, Dept Upper GI Dis, Hepatol Div, Stockholm, Sweden
[3] Karolinska Univ Hosp, Stockholm, Sweden
[4] Harran Univ, Dept Gastroenterol, Sanliurfa, Turkiye
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 81卷 / 01期
关键词：
D O I：
10.1016/j.jhep.2024.02.022
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：e41 / e42
页数：2
相关论文
共 50 条
  • [21] Triple therapy with mycophenolate mofetil versus azathioprine
    Muñiz, ML
    Amenabar, J
    Gómez-Ullate, P
    Urbizu, J
    Lampreabe, I
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 1144 - 1146
  • [22] Efficacy of Mycophenolate Mofetil vs Standard Therapy for the Treatment of Autoimmune Hepatitis: An Updated Meta-Analysis
    Ijaz, Osama
    Shahzad, Zoha
    Rao, Asad Gul
    Ilmaguook, Badr
    Rauf, Faateh A.
    Shah, Syed Muhammad Ali
    Ali, Rahila
    Rehman, Khawaja Abdul
    Bajwa, Muhammad Talha
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1291 - S1292
  • [23] Mycophenolate Acid vs Mycophenolate Mofetil Therapy
    Sanchez-Lazaro, I. J.
    Almenar, L.
    Martinez-Dolz, L.
    Portoles, M.
    Rosello, E.
    Rivera, M.
    Salvador, A.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (08) : 3041 - 3043
  • [24] Reply to: Comments on "An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis"
    Snijders, Romee J. A. L. M.
    Stoelinga, Anna E. C.
    van Hoek, Bart
    Drenth, Joost P. H.
    JOURNAL OF HEPATOLOGY, 2024, 81 (01) : e43 - e44
  • [25] The cost-effectiveness of mycophenolate mofetil (MMF) as first-line therapy in active lupus nephritis
    Wilson, E. C.
    Jayne, D. R.
    Dellow, E.
    Fordham, R. J.
    VALUE IN HEALTH, 2007, 10 (03) : A105 - A106
  • [26] Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy
    Devlin, SM
    Swain, MG
    Urbanski, SJ
    Burak, KW
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 18 (05) : 321 - 326
  • [27] A Case of Repeat Kidney Transplant Intolerant to Multiple First-line Immunosuppressive Agents Mycophenolate Mofetil, Azathioprine, and Calcineurin Inhibitors
    Arora, Puneet
    Duggal, Rajan
    Garg, Deepak
    Naseem, Tarique
    INDIAN JOURNAL OF TRANSPLANTATION, 2024, 18 (04) : 465 - 468
  • [28] Editorial: tailoring mycophenolate mofetil rescue therapy for success in autoimmune hepatitis
    Czaja, Albert J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (11) : 1449 - 1450
  • [29] MYCOPHENOLATE MOFETIL AS SECOND-LINE THERAPY FOR AUTOIMMUNE HEPATITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Santiago, Priscila
    Tamariz, Leonardo
    Schwartz, Ingrid
    Levy, Cynthia
    GASTROENTEROLOGY, 2018, 154 (06) : S1098 - S1098
  • [30] Systematic review with meta-analysis: mycophenolate mofetil as a second-line therapy for autoimmune hepatitis
    Santiago, Priscila
    Schwartz, Ingrid
    Tamariz, Leonardo
    Levy, Cynthia
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (07) : 830 - 839
12345